Afterpay Now Available. T&Cs apply*.
Governance hero

Governance & Board of Directors

We are dedicated to the highest standards of corporate behaviour and accountability throughout all levels of the organisation.

The Blackmores corporate governance practices have been developed by the Board using the framework of the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations (4th ed.). You can view our governance policies below:

Board of Directors

Anne Templeman-Jones

Anne Templeman-Jones BCom, EMBA, Masters in Risk Management, CA, FAICD

Chair and Independent Non-Executive Director

- Term: Chair and Director since 28 October 2020
- Board Committees: Audit Committee (Member), People & Remuneration Committee (Member), Risk & Technology Committee (Member), Nominations Committee (Chair)

Following the October 2020 AGM, Anne joined the Board as Chair and is a member of all Board Committees. A member of the Institute of Chartered Accountants Australia New Zealand, with a Masters in Risk Management, Anne brings significant ASX listed Board, strategy, financial, corporate governance, risk management, and operational experience with a focus on ESG and Cyber security with a disciplined systems thinking approach.   

The Therapeutic Goods Administration regulates the sector within which Blackmores operates to ensure safe and effective outcomes for consumers in relation to the healthcare products they use.  Anne is able draw on experience in highly regulated and diverse sectors (financial services and health services, manufacturing and supply chain, and global engineering services across multi jurisdictions (Australia, India, China and South-East Asia, the United States and Europe) to apply a focus on ensuring delivery of customer safety and service, employee wellbeing, reputation, company and shareholder value.   

Anne currently serves as a Non-Executive Director of the ASX listed Commonwealth Bank of Australia Limited, where she is Chair of its Audit Committee and a member of its Risk Committee, and as a Non-Executive Director of ASX listed Worley Limited where she is Chair of its Audit and Risk Committee. Anne is also a director of New South Wales Treasury Corporation (TCorp) and the Cyber Security Research Centre Ltd.

Anne is the former Chairperson of Commonwealth Bank’s financial subsidiaries and has served on the boards of GUD Holdings Limited, The Citadel Group Ltd, Cuscal Ltd, HT&E Limited, Pioneer Credit Ltd, Notre Dame University, TAL Superannuation Fund and HBF Limited.
Anne is based in Sydney, Australia.


David Ansell BA (Communication), GAICD

Independent Non-Executive Director

- Term: Director since 22 October 2013 
- Board Committees: People & Remuneration Committee (Member)

David has enjoyed a highly successful career in consumer-facing organisations in Australia, Asia and the United States.

David played a pivotal role in the start-up years of Foxtel, was CEO of advertising agency Saatchi & Saatchi, Managing Director of Mars Incorporated in Australia, and President of a global Mars unit based in the United States.

David has a strong operating and supply chain skill set and a deep understanding of brand and customer strategy. David recently stepped down as Managing Director of Jacobs Douwe Egberts Peets, after six years running Australia and New Zealand’s largest pure play coffee Company. Since then, he has led the acquisition of the Campos Coffee Company, which he now Chairs as an Independent Director.

David is a former Director of the peak body of cycling in this country, Cycling Australia, where he served for five years until early 2020.

David is based in Sydney, Australia.



Erica Mann BSc, Dip Mark. Manag., GAICD

Independent Non-Executive Director

- Term: Director since 20 September 2021 
- Board Committees: Risk & Technology Committee (Member)

Erica joined the Board in September 2021. Erica has over 30 years of experience in roles of increasing responsibility across the healthcare industry and more than 25 years of active P&L management. Erica most recently served as President & Head of Bayer’s Global Consumer Health Division where she directed every aspect of one of the world’s leading global consumer selfcare companies. Prior to joining Bayer, Erica was the Global President and General Manager of Pfizer (Wyeth) Nutrition. 

Erica has worked in highly regulated, complex multi-channel and multi product environments across multiple jurisdictions. She has significant experience in both small- & large-scale health related M&A and integration. She has deep expertise in extracting strategy from health trends with a strong focus on culture, risk management and ESG.

Erica has a strong understanding of complementary medicines and naturopathic principles and deep experience in over-the-counter therapeutic goods. She chaired the board of the World Self-Medication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements, and held executive positions on the boards of South African Pharmaceutical Manufacturers’ Association, Medicines Australia and International Association of Infant Food Manufacturers.

Erica currently serves as a Non-Executive Director of Kellogg Company (NYSE: K), Perrigo Company PLC (NYSE: PRGO) and Supervisory Board Member at Koninklijke DSM N.V (AMS: DSM). She recently completed Berkeley Law School’s ESG certificate course. Fortune named Erica to the list of the 50 Most Powerful Women International in 2016 and 2017. Erica was also selected by Nelson Mandela to participate in the Trade Mission to the UK in 1996.

Erica is based in Sydney, Australia.



Stephen Roche BBUS (Finance & Banking), FAICD

Independent Non-Executive Director

- Term: Director since 20 September 2021 
- Board Committees: Nominations Committee (Member), People & Remuneration Committee (Chair), Audit Committee (Member)

Stephen has extensive board and senior executive/CEO experience in strategy (including customer and marketing strategies), business development and supply chains across pharmacy, healthcare, retail and consumer markets. Significantly, he has over 20 years’ experience in Australian and New Zealand pharmacy markets, including serving as Deputy Chairman of the National Pharmaceutical Services Association.

Stephen was previously Managing Director of Bridgestone Australia & New Zealand and he has also been Managing Director and CEO of ASX listed Australian Pharmaceutical Industries Limited for eleven years from August 2006 until February 2017. Previously, he had senior executive roles at Mayne and Faulding extending across health and primary care services, distribution and business development. Stephen was also previously Vice Chairman, Bridgestone China & Asia Pacific retiring in March 2020 and the founding Chairman of the Priceline Sisterhood Foundation until June 2018 and a Non-Executive Director of both Epworth Healthcare (2017-2018) and Gold Cross Products and Services (2004 – 2007).

Stephen is currently a Non-Executive Director of Myer Family Investments Pty Ltd and ASX listed Baby Bunting Limited and a director of the Adelaide Football Club.

Stephen is based in Adelaide, Australia.


Wendy Stops

Wendy Stops BAppSc (Information Technology), GAICD

Independent Non-Executive Director

- Term: Director since 28 April 2021 
- Board Committees: Risk & Technology Committee (Chair), Nominations Committee (Chair), People & Remuneration Committee (Member)

Wendy joined the Board in April 2021 and is Chair of the Risk and Technology Committee. She brings deep global information technology, business operations and risk management experience with executive leadership roles in the Asia Pacific region (variously incorporating South-East Asia, China, India, Korea and Japan) and globally.

Wendy is currently a Non-Executive Director with the ASX listed Coles Group and Fitted for Work, a Council Member of the University of Melbourne, Chair of the Industry Advisory Board for the Melbourne Business School’s Centre for Business Analytics, a member of the Digital Experts Advisory Panel for the Department of Prime Minister and Cabinet’s Digital Taskforce and a member of the AICD’s Governance of Technology and Innovation Panel.

She was previously a Non-Executive Director of the ASX listed Commonwealth Bank of Australia (2015-2020) and ASX listed Altium Ltd (2018-2019).

Wendy is based in Melbourne, Australia.


Alastair Symington

Alastair Symington BEc, PostGradDip IntBus, MAICD

Chief Executive Officer and Managing Director

- Term: Appointed 1 October 2019 

Alastair joined Blackmores as Group CEO and Managing Director in September 2019. He is a global business leader and brand builder with more than 24 years of consumer goods experience in health and beauty across multiple geographies. 

Alastair spent 10 years in a wide range of sales and marketing roles with Nestlé and Gillette in Australia, before joining Procter & Gamble (P&G) in 2005 and moving to Singapore in 2008 where he was responsible for strategy and planning across APAC for the beauty and grooming categories. During this time he led global and regional teams, including as China Managing Director for Wella based in Shanghai.  

In 2016, Alastair joined Coty as part of the merger between P&G specialty beauty brands and the former Coty company, helping to transform it into the third largest beauty company in the world. In his last role at Coty, he was Senior Vice President of APAC, Latin America and the Middle East.  

Alastair has a Bachelor of Economics and a Post-Graduate Diploma in International Business from Monash University, and studied Mandarin while living and working in Shanghai. He is passionate about finding ways to connect more people to holistic health solutions, believing that healthy people and their pets naturally lead to a healthier planet. 

Alastair is based in Sydney, Australia.


Sharon Warburton

Sharon Warburton BBus (Accounting & Business Law), FCA, FAICD, FAIB

Independent Non-Executive Director

- Term: Director since 28 April 2021
- Board Committees: Audit Committee (Chair), Risk & Technology Committee (Member), Nominations Committee (Member)

Sharon joined the Board in April 2021 and is Chair of the Audit Committee. She is a Fellow of the Institute Chartered Accountants Australia New Zealand and has extensive board and executive experience in corporate strategy, business operations (including foreign joint ventures), finance, accounting and risk management, along with significant expertise in governance and remuneration.  Sharon has experience in working with new and existing businesses in China, India, Indonesia and other South-East Asian countries as well as significant business transformation experience including autonomy, e-commerce and other digital strategies.

She is currently a Non-Executive Director and Chair of the Audit and Risk Committee of ASX listed Wesfarmers Limited, as well as being a Non-Executive Director of ASX listed Worley Limited and ASX listed Northern Star Resources Limited. Sharon is also a director of Karlka Nyiyaparli Aboriginal Corporation, Thiess Group Holdings Pty Limited and the Perth Children’s Hospital Foundation.

Sharon has also been a part-time member of the Takeovers Panel since 2015 and is an Adjunct Professor in Leadership and Strategy at Curtin University’s Faculty of Business and Law.

Sharon is based in Perth, Australia.